sumi.news
Search
Following
Sign in
← Back to news
Y
Yahoo Finance
RSS Feed
finance.yahoo.com
finance.yahoo.com/rss
Follow
Latest
Sat Jan 31
JPMorgan Lifts PT on Equinor ASA (EQNR) to NOK 240 From NOK 220
2d
Y
BofA Lifts PT on Kinross Gold Corporation (KGC) to $42.75 from $37.50, Here’s Why
2d
Y
Wells Fargo Lifts PT on Keurig Dr. Pepper Inc. (KDP) to $40 from $35 – Here’s Why
2d
Y
Vale S.A. (VALE) Gets Downgraded to Neutral from Buy by BofA, Here’s Why
2d
Y
Grupo Santander Downgrades BP p.l.c. (BP) to Neutral from Outperform
2d
Y
Novo Nordisk A/S (NVO) Announces FDA Approval of Three New Indications for Sogroya
2d
Y
Pfizer Inc. (PFE) and Astellas Pharma Announce Positive Results From the Phase 3 EV-304 Clinical Trial for PADCEVTM
2d
Y
Why Eni S.p.A. (E) is One of the Best Cheap Stocks Under $50 to Buy Right Now
2d
Y
Cantor Fitzgerald Lifts PT on Innoviva, Inc. (INVA) to $32 from $31 – Here’s Why
2d
Y
Guggenheim Raises PT on Phathom Pharmaceuticals (PHAT) to $25 From $20, Here’s Why
2d
Y
Is Halozyme Therapeutics (HALO) a Buy Post Earnings?
2d
Y
Aurinia Pharmaceuticals (AUPH) Reports Financial Results for Three and Twelve Months Ended December 31, 2025
2d
Y
Catalyst Pharmaceuticals (CPRX) Reports Record Q4 and Full Year 2025 Results
2d
Y
Wells Fargo Cuts PT on Sarepta Therapeutics (SRPT) to $38 From $45
2d
Y
Deutsche Bank Cuts PT on Harmony Biosciences Holdings (HRMY) to $30 From $31
2d
Y
TD Cowen Lifts PT on Royalty Pharma Plc (RPRX) to $50 from $45, Here’s Why
2d
Y
TG Therapeutics (TGTX) Reports Financial Results for Q4 and Full Year 2025
2d
Y
Wells Fargo Cuts PT on Soleno Therapeutics (SLNO) to $110 From $114 – Here’s Why
2d
Y
Canaccord Lifts PT on BioMarin Pharmaceutical (BMRN) to $104 From $98 – Here’s Why
2d
Y
Is Jazz Pharmaceuticals (JAZZ) One of the Best Cheap Biotech Stocks to Buy Now?
2d
Y
Is the Trump Bull Market on Its Last Leg? 4 Historically Accurate Indicators Offer a Clear Answer.
2d
Y
Analyst Sentiment on SS&C Technologies (SSNC) Remains Strong Despite Lingering AI Risks
2d
Y
Truist Analysts Mixed on EPAM Systems (EPAM) Despite Revenue, Operating Income Beat
2d
Y
Jefferies Bullish on ICON (ICLR) Despite Share Price Decline
2d
Y
Leidos Holdings (LDOS) Advances Operations as Terminal Flight Data Manager System Goes Live At Reagan National Airport
2d
Y
Cascades Q4 Earnings Call Highlights
2d
Y
CCL Industries Q4 Earnings Call Highlights
2d
Y
BTB Real Estate Investment Trust Q4 Earnings Call Highlights
2d
Y
Boralex Q4 Earnings Call Highlights
2d
Y
Black Diamond Group Q4 Earnings Call Highlights
2d
Y
Amerigo Resources Q4 Earnings Call Highlights
2d
Y
Barclays Lowers PT on ACV Auctions (ACVA)
2d
Y
Morgan Stanley Lowers PT on Playtika Holding (PLTK)
2d
Y
Clover Health Investments (CLOV) Posts Q4 2025 Earnings
2d
Y
N-able (NABL) Expands Anomaly Detection Capabilities For Cove Data
2d
Y
MiMedx Group (MDXG) Delivers Record Full Year Revenue
2d
Y
Optimum Communications (OPTU) Misses Q4 2025 EPS Estimates
2d
Y
Gogo Inc. (GOGO) Posts FQ4 2025 Earnings, Here’s What You Need to Know
2d
Y
B. Riley Lowers PT on AMC Entertainment Holdings (AMC), Here’s Why
2d
Y
Payoneer Global (PAYO) Crosses $1 Billion in Annual Revenue
2d
Y
FIS Gets Lower Baird Target Following Updated Financial Outlook
2d
Y
Agilent (A) Gets Lower Goldman Sachs Target Despite Long-Term Growth Confidence
2d
Y
TD Cowen Sees Carlyle (CG) Entering New Growth Cycle after Strategic Reset
2d
Y
Arthur J. Gallagher (AJG) Upgraded by Mizuho as Insurance Brokerage Outlook Improves
2d
Y
Constellation Energy (CEG) Positioned for Growth as PJM Market Developments Support Demand
2d
Y
CRH Target Increased as Acquisition Activity and Capital Investment Continue
2d
Y
The Saturday Spread: Using an Overlooked Indicator to Assess True Market Risk
2d
Y
Brown & Brown (BRO) Seen Well Positioned Amid Limited AI Disruption Risk, Mizuho Says
2d
Y
Walmart (WMT) Coverage Reinstated With Bullish Outlook from BofA
2d
Y
Chubb (CB) Price Target Raised Following Property and Casualty Sector Results
2d
Y
More →